Skip to main content
MDLN
NASDAQ Finance

Carlyle Group Entities Restructure $9.87 Billion Medline Stake

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$44.24
Mkt Cap
$56.884B
52W Low
$38
52W High
$45.5
52W Position info
16% above low
Off High info
2.8% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

MDLN sits 16% above its 52-week low of $38 on light trading volume (0.2× avg).

Summary

Carlyle Group entities reported the internal transfer of 223.1 million Medline shares, valued at approximately $9.87 billion, to affiliated entities for no consideration.


Key Events · Ownership and Investor Activity · MDLN

  • Significant Share Disposition

    Carlyle Group entities disposed of 223,109,715 shares of Medline, representing a substantial portion of their indirect holdings.

  • Internal Transfer, Not Market Sale

    The transaction was an internal transfer to affiliated entities for no consideration, as indicated by the 'J' transaction code and footnotes, not an open-market sale.

  • Valuation of Disposed Shares

    The disposed shares are valued at approximately $9.87 billion based on the current stock price, highlighting the scale of the internal restructuring.

  • Lock-up Agreement in Place

    The affiliated entities receiving the shares are subject to a lock-up agreement, which restricts immediate market sales and dampens direct market impact.


Analysis · MDLN · Finance

This Form 4 filing indicates a significant internal restructuring of Medline shares by Carlyle Group entities, a major 10% owner. While the disposition of 223.1 million shares, valued at approximately $9.87 billion, is substantial, it represents transfers to affiliated entities for no consideration rather than open-market sales. The affiliated entities are also bound by a lock-up agreement, which limits the immediate market impact. This event primarily reflects a change in the reporting structure of Carlyle's indirect holdings in Medline, rather than a direct signal of a change in investment thesis or a liquidity event for the market.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDLN was trading at $44.24 on NASDAQ in the Finance sector, with a market capitalization of approximately $56.9B. The 52-week trading range was $38.00 to $45.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDLN - Latest Insights

MDLN
Nov 04, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $40.35
Real-time Price: $40.59 info
Change: +$0.240 (+0.59%) info
Market Cap: $53.56B info
MDLN
Nov 04, 2026, 7:34 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.15
Real-time Price: $40.59 info
Change: +$3.44 (+9%) info
Market Cap: $53.56B info
MDLN
Nov 04, 2026, 7:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $34.22
Real-time Price: $40.59 info
Change: +$6.37 (+19%) info
Market Cap: $53.56B info
MDLN
Oct 29, 2026, 12:23 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $32.44
Real-time Price: $40.59 info
Change: +$8.15 (+25%) info
Market Cap: $53.56B info
MDLN
Oct 21, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.31
Real-time Price: $40.59 info
Change: +$5.28 (+15%) info
Market Cap: $53.56B info